USE OF NUCLEAR MATERIAL TO THERAPEUTICALLY REPROGRAM DIFFERENTIATED CELLS - Patent 1844137

(19)

(11)

EP 1 844 137 A2

(12)

(88)	Date of publication A3:
	05.10.2006

(43)	Date of publication:
	17.10.2007 Bulletin 2007/42

(21)	Application number: 06734404.4

(22)	Date of filing: 02.02.2006

(51)

International Patent Classification (IPC):

C12N 5/00^(2006.01)

(86)	International application number:
	PCT/US2006/004077

(87)	International publication number:
	WO 2006/084229 (10.08.2006 Gazette 2006/32)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30)

Priority:

02.02.2005 US 649847 P
16.02.2005 US 60131

(71)	Applicant: PrimeGen Biotech LLC
	Irvine, CA 92618 (US)

(72)	Inventors:
	SAYRE, Chauncey, B. Irvine, California 92604 (US) SILVA, Francisco, J. Rancho Cucamonga, California 91730 (US)

(74)	Representative: Green, Mark Charles et al
	Urquhart-Dykes & Lord LLP 30 Welbeck Street London W1G 8ER London W1G 8ER (GB)

(54)	USE OF NUCLEAR MATERIAL TO THERAPEUTICALLY REPROGRAM DIFFERENTIATED CELLS